drug
rizatriptan benzoate ODT
Marketedupdated 3mo agoby Bionpharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6all catalysts(0)
nothing on the calendar yet
Trials studying rizatriptan benzoate ODT
- phase3Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
- phase3Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
- phase3Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)
- phase3Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)
- phase3A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
- phase3Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)
- phase3A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
- phase1Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 30, 2034
~8.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Jul 30, 2034compositionUS 9301948
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that